Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
33.93
+0.12 (0.35%)
At close: Oct 28, 2025
SHA:688139 Revenue
Qingdao Haier Biomedical Co.,Ltd had revenue of 506.51M CNY in the quarter ending June 30, 2025, a decrease of -5.57%. This brings the company's revenue in the last twelve months to 2.26B, up 1.00% year-over-year. In the year 2024, Qingdao Haier Biomedical Co.,Ltd had annual revenue of 2.28B with 0.13% growth.
Revenue (ttm)
2.26B
Revenue Growth
+1.00%
P/S Ratio
4.72
Revenue / Employee
787.18K
Employees
2,807
Market Cap
10.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.28B | 2.94M | 0.13% |
| Dec 31, 2023 | 2.28B | -583.15M | -20.36% |
| Dec 31, 2022 | 2.86B | 738.18M | 34.72% |
| Dec 31, 2021 | 2.13B | 723.83M | 51.63% |
| Dec 31, 2020 | 1.40B | 389.51M | 38.47% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi AppTec | 43.89B |
| Huadong Medicine | 42.62B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |
| Shanghai Fosun Pharmaceutical (Group) | 40.12B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Jiangsu Hengrui Medicine | 30.15B |
| Zhejiang NHU Company | 22.87B |
| Aier Eye Hospital Group | 21.94B |